New Cells for New Vaccines IV - Changing the Vaccine Landscape: Recombinant Systems

Wilmington, Delaware
Sunday, October 11, 2009
New Cells for New Vaccines IV - Changing the Vaccine Landscape: Recombinant Systems
Sunday, October 11, 2009 - Wednesday, October 14, 2009

Hotel du Pont (Conference Venue)
11th & Market Streets
Wilmington, Delaware

The International Association for Biologicals and the Fraunhofer USA Center for Molecular Biotechnology invite you to participate in “New Cells for New Vaccines IV - Changing the Vaccine Landscape: Recombinant Systems” October 11-14, 2009.

Workshop Overview:

This workshop, fourth in a series, will address progress on new substrates and recombinant systems for vaccine development currently approaching clinical trials including yeast, insect and plant cells.


Workshop Topics Include:

  • Establishing target profiles
  • Molecular characterization
  • Biological properties
  • Rational design of adjuvants,
  • Delivery systems
  • Protein aggregation and stability
  • Storage and distribution
  • The Current Global Situation: Expanding Markets, Emerging Challenges


Speakers are recognized experts in their fields and include:

  • Dr. John W. Boslego, PATH
  • Dr. Arthur Elliott, BARDA
  • Dr. Tudor Arvinte, Therapeomic
  • Dr. William Egan, Pharmanet Development Group
  • Dr. Michael Callahan, Director, Biodefense and Mass Casualty Care, CIMIT, Massachusetts General Hospital, Harvard Medical School
  • Dr. Alan Shaw, VaxInnate
  • Dr. Ozzie Berger, GlaxoSmithKline Biologicals
  • Dr. Jason Hollister, Protein Sciences
  • Dr. Nick Valiante, Novartis
  • Dr. Karin Lövgren Beugtsson, Isconova
  • Dr. Steven Pincus, Analytical Operations, Novavax
  • Dr. Vidadi Yusibov, Fraunhofer USA Center for Molecular Biotechnology
  • Dr. Yoseph Shaaltiel, Protalix Biotherapeutics
  • Dr. Steven Reed, IDRI
  • Dr. James Baker, NanoBio
  • Dr. Maria Elena Bottazzi, Human Hookworm Vaccine Initiative
  • Dr. Ezio Bonvini, MacroGenics
  • Dr. Phil Krause, FDA
  • Dr. Gale Smith, Novavax
  • Dr. Prakash Sambhara, CDC
  • Dr. Russ Middaugh, University of Kansas
  • Dr. Jeff Drew, Stabilitech
  • Dr. Alain Rolland, Vical
  • Dr. Majid Mehtali, Vivalis
  • Dr. Debbie Higgins, Neugenesis
  • Dr. Robert Erwin, iBioPharma
  • Dr. Volker Sandig, ProBioGen
  • Dr. Arifa Khan, FDA
  • Dr. Rebecca Sheets, NIH/NIAID
  • Dr. William Warren, VaxDesign
  • Dr. Charles Squires, Pfenex, Inc.
  • Dr. Ulrich Kalinke, Twincore
  • Dr. Ruben Donis, CDC
  • Dr. Phillip Gomez, PRTM Management Consultants
  • Dr. Geoffrey Hodge, Xcellerex
  • Dr. Barry Holtz, Holtz BioPharma Consulting
  • Dr. Jessica Chichester, Fraunhofer USA Center for Molecular Biotechnology
  • Dr. Armin Braun, Fraunhofer ITEM 
  • Dr. Ulrich Kalinke, Twincore
  • Dr. Darrick Carter, IDRI
  • Dr. John Schiller, Laboratory of Cellular Oncology, Division of Principal Sciences, National Cancer Institute, NIH
  • Dr. Bryce Chackerian, Assistant Professor, Molecular Genetics and Microbiology, University of New Mexico
  • Dr. Dave Lanar, Walter Reed Army Institute of Research
New Cells for New Vaccines IV will be of interest to scientists in the biotechnology and pharmaceutical industries involved in vaccine development and production, as well as academics, regulatory and public health authorities, and medical and veterinary experts. The venue and the meeting provide a perfect opportunity to interact with colleagues from industry, academia and regulatory agencies to exchange views and ideas and explore potential collaboration.

    The Hotel du Pont is conveniently located in downtown Wilmington, Delaware - a two hour drive from New York or Washington, D.C. and one hour from Baltimore, Maryland or BWI International Airport. The hotel is just five blocks off I-95, minutes from the Wilmington train station and 25 minutes from the Philadelphia International Airport (PHL).

    For information regarding abstracts contact:
    Dr. Lars Haaheim
    Email:
    lhaaheim@fraunhofer-cmb.org
    Phone: +1 302 356 5903

     

    Contact Information

    • Dale Ervin
      Conference Coordinator
      Phone: 302-369-3034

    Payment Instructions

    • Make Checks Payable To:
      New Cells for New Vaccines

      Mail check to: 
      Fraunhofer USA Center for Molecular Biotechnology
      Attn: NCNV Conference
      9 Innovation Way
      Suite 200
      Newark, DE 19711

      Bank Wire Information: 
      Please contact - Dale Ervin
      Conference Coordinator
      302-369-3034

    Workshop Sponsors & Exhibitors:

         
         
     
        



     
     

    © 2019
    Quick, easy and affordable online event registration and event management software for all event sizes.